Literature DB >> 17692447

Successful augmentation with aripiprazole in clomipramine-refractory obsessive-compulsive disorder.

Felipe Filardi da Rocha, Humberto Correa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17692447     DOI： 10.1016/j.pnpbp.2007.07.008

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN： 0278-5846            Impact factor:   5.067


× No keyword cloud information.
  7 in total

1.  Aripiprazole augmentation in treatment-refractory obsessive-compulsive disorder.

Authors:  Rahul Sarkar; Julia Klein; Stephanie Krüger
Journal:  Psychopharmacology (Berl)       Date:  2008-02-10       Impact factor: 4.530

2.  Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.

Authors:  Kimberly A Stigler; Jonathan T Diener; Arlene E Kohn; Lang Li; Craig A Erickson; David J Posey; Christopher J McDougle
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-06       Impact factor: 2.576

Review 3.  Circadian rhythms in obsessive-compulsive disorder.

Authors:  Klaus W Lange; Katharina M Lange; Joachim Hauser; Lara Tucha; Oliver Tucha
Journal:  J Neural Transm (Vienna)       Date:  2012-04-28       Impact factor: 3.575

4.  Aripiprazole augmentation in patients with resistant obsessive compulsive disorder: a pilot study.

Authors:  Roberto Delle Chiaie; Pierluigi Scarciglia; Massimo Pasquini; Maria Caredda; Massimo Biondi
Journal:  Clin Pract Epidemiol Ment Health       Date:  2011-05-27

5.  Current management of obsessive and phobic states.

Authors:  Serena Goljevscek; Livia A Carvalho
Journal:  Neuropsychiatr Dis Treat       Date:  2011-09-30       Impact factor: 2.570

Review 6.  Critical Review of the Use of Second-Generation Antipsychotics in Obsessive-Compulsive and Related Disorders.

Authors:  Dongmi Kim; Nicole L Ryba; Julie Kalabalik; Ligia Westrich
Journal:  Drugs R D       Date:  2018-09

Review 7.  Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).

Authors:  Antonio Del Casale; Serena Sorice; Alessio Padovano; Maurizio Simmaco; Stefano Ferracuti; Dorian A Lamis; Chiara Rapinesi; Gabriele Sani; Paolo Girardi; Georgios D Kotzalidis; Maurizio Pompili
Journal:  Curr Neuropharmacol       Date:  2019       Impact factor: 7.363
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.